Sanjiv Patel - 17 Aug 2026 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Reporting relationship: President and CEO, Director
Issuer ticker: RLAY
Reported as of: 17 Aug 2026
Net transaction value: -$979,886
SEC form: 4
Accepted by SEC: 18 Aug 2026, 16:17:50 UTC
Prior SEC filing: 08 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Soo-Yeun Lim, as attorney-in-fact

Key filing fact

Sanjiv Patel filed Form 4 for Relay Therapeutics, Inc. (RLAY) on 18 Aug 2026.

Key facts

This page summarizes Sanjiv Patel's Form 4 filing for Relay Therapeutics, Inc. (RLAY).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Aug 2026, 16:17.

Change

Previous filing in this sequence was filed on 08 Jul 2026.
Current net transaction value: -$979,886.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001816210 Primary reporting owner

Patel Sanjiv

Relationship: President and CEO, Director
Address: C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE
Signature: /s/ Soo-Yeun Lim, as attorney-in-fact
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RLAY transaction

Common Stock

Sale

Transaction value: $979,886
Shares: -48,199
Change %: -7.8%
Price: $20.33
Shares after: 567,699
Date: 17 Aug 2026
Ownership: Direct
Footnotes: F1, F2

RLAY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 199,548
Date: 17 Aug 2026
Ownership: By The Patel Family Irrevocable Trust of 2019
Footnotes: F3

RLAY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 687,355
Date: 17 Aug 2026
Ownership: By The SSP Irrevocable Trust of 2020
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $19.56 to $20.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F3

These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.